BLUUMBIO GTM brain
BluumBio develops microbial remediation products and services for organizations cleaning contaminated sites and industrial wastewater.
category
Environmental bioremediationmarket profile
- text: Industrial site owners and remediation firms face expensive, unpredictable cleanup of petroleum and other persistent pollutants.
- text: PFAS treatment is an active research and commercialization area; BluumBio's PFAS program has received Phase I research funding.
personas
- title: Environmental remediation project managerpains:
- Site conditions and mixed contaminants make cleanup timelines unpredictable.
- Traditional approaches may be expensive or disruptive at scale.
- title: Industrial environmental health and safety directorpains:
- Legacy contamination creates long-lived liability and monitoring obligations.
- Wastewater treatment must fit operating constraints and the site's specific contaminant profile.
- title: Environmental consulting or remediation firm principalpains:
- Clients need credible site-specific evidence before selecting a remediation approach.
- Existing methods can be resource intensive for difficult chemicals.
icp
- text: Oil, chemical and other industrial operators with contaminated soil or water, legacy sites or industrial wastewater streams.
- text: Environmental remediation firms and site consultants that assess and deploy treatments for client sites.
message pillars
- text: Use biological processes to restore contaminated environments.
- text: Test suitability against a particular site before committing to field work.
- text: Make progress on industrial chemicals through microbial products.
objections
- objection: Will the microbes work under our site's specific conditions?response: Start with a site-specific bench-scale evaluation and agree on contaminants, endpoints and field criteria.
- objection: Is the PFAS solution commercially proven for our site?response: Ask for current contaminant-specific validation and field data; public funding describes a research-stage PFAS program.
- objection: How does this compare with established treatment on cost and timeline?response: Scope the matrix, volumes and monitoring requirements, then compare a site-specific proposal against conventional options.
competitors
- name: Allonniawhy: Develops biological approaches to industrial pollution and waste remediation.
- name: BioNorth Solutionswhy: Works in soil rehabilitation and environmental remediation.
- name: Mycorrhiza Biotechwhy: Listed among BluumBio competitors in environmental biotechnology.
influencers
- name: Katherine Frenchurl: https://eqtgroup.com/news/eqt-foundation-invests-in-bluumbio-harnessing-the-power-of-nature-to-clean-up-pollutionwhy: Founder and CEO speaking about commercialization and field trials.
keywords
- petroleum soil bioremediation
- industrial wastewater biological treatment
- PFAS bioremediation
- contaminated site microbial treatment
- legacy site remediation
- in situ pollution cleanup
voice
- Mission-driven and hopeful
- Scientifically grounded
- Candid about remediation challenges
signals
- text: An industrial owner is assessing petroleum-contaminated soil or a legacy site redevelopment.
- text: A remediation firm is seeking a biological treatment pilot for a difficult contaminant matrix.
- text: A site operator is investigating emerging PFAS cleanup options and can participate in validation.
pricing
model: unknown
motion
sales_ledchannels
- industry partnerships
- events
- research and grants
confidence
mediumFounders
- name: Katherine Frenchtitle: Founderrole: Founderbio: I am a biologist dedicated to developing new technologies that harness nature to clean up the environment. I completed my PhD in the Department of Plant Sciences at Oxford University in 2016. Since then, I have worked at UC Berkeley and Lawrence Berkeley National Lab to engineer organisms for bioremediation and to understand the environmental effects of genetically engineered bacteria and plants. BluumBio combines my passion for sustainability with my commitment to bioinovation.